The government is considering increasing the import duty on active pharmaceutical ingredients (APIs) to 20-25% from the current 10%, to help boost local manufacturing of the bulk drugs. A committee of experts formed by the DoP had suggested increasing the customs duty on APIs.
The Department of pharmaceuticals is mulling a proposal to increase the custom duty as it pushes to make india self reliant in API in industry.